Evidence map›Paper›PMID 33755697›Full record

ArticlePloS one2021

Characteristics of hospitalized patients during a large waterborne outbreak of Campylobacter jejuni in Norway.

Nicolay Mortensen, Solveig Aalstad Jonasson, Ingrid Viola Lavesson, Knut Erik Emberland, Sverre Litleskare, Knut-Arne Wensaas, Guri Rortveit, Nina Langeland, Kurt Hanevik

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 14 citations in OpenAlex.

  1. A Review of Essential Oils with Anti-Foods (Basel, Switzerland) · 2026
    Review
  2. International journal of microbiology · 2026
    Review
  3. Food and waterborne parasitology · 2025
    Review
  4. Article
  5. Observational
  6. Article
  7. Whole genome characterization of thermophilicFrontiers in microbiology · 2023
    Article
  8. Article
  9. Article
  10. Article
  11. Global epidemiology of campylobacteriosis and the impact of COVID-19.Frontiers in cellular and infection microbiology · 2022
    Review
  12. Article
  13. Treatment with the Probiotic Product AviguardInternational journal of molecular sciences · 2021
    Article
  14. Article
  15. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Nicolay MortensenChildren and Youth Clinic, Haukeland University Hospital, Bergen, Norway.ORCID 0000-0001-7121-6122
Solveig Aalstad JonassonDepartment of Infectious Diseases, Haukeland University Hospital, Bergen, Norway.
Ingrid Viola LavessonEmergency Clinic, Haukeland University Hospital, Bergen, Norway.
Knut Erik EmberlandResearch Unit for General Practice, NORCE Norwegian Research Centre, Bergen, Norway.
Sverre LitleskareResearch Unit for General Practice, NORCE Norwegian Research Centre, Bergen, Norway.
Knut-Arne WensaasResearch Unit for General Practice, NORCE Norwegian Research Centre, Bergen, Norway.
Guri RortveitDepartment of Global Public Health and Primary Care, University of Bergen, Bergen, Norway.
Nina LangelandDepartment of Clinical Science, University of Bergen, Bergen, Norway.
Kurt HanevikDepartment of Clinical Science, University of Bergen, Bergen, Norway.ORCID 0000-0002-1466-2326
Haukeland University Hospital · NONORCE Research AS · NOUniversity of Bergen · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Very few reports describe all hospitalized patients with campylobacteriosis in the setting of a single waterborne outbreak. This study describes the demographics, comorbidities, clinical features, microbiology, treatment and complications of 67 hospitalized children and adults during a large waterborne outbreak of Campylobacter jejuni in Askoy, Norway in 2019, where more than 2000 people in a community became ill. We investigated factors that contributed to hospitalization and treatment choices. Data were collected from electronic patient records during and after the outbreak. Fifty adults and seventeen children were included with a biphasic age distribution peaking in toddlers and middle-aged adults. Most children, 14 out of 17, were below 4 years of age. Diarrhea was the most commonly reported symptom (99%), whereas few patients (9%) reported bloody stools. Comorbidities were frequent in adults (63%) and included cardiovascular disease, pre-existing gastrointestinal disease or chronic renal failure. Comorbidities in children (47%) were dominated by pulmonary and gastrointestinal diseases. Adult patients appeared more severely ill than children with longer duration of stay, higher levels of serum creatinine and CRP and rehydration therapy. Ninety-two percent of adult patients were treated with intravenous fluid as compared with 12% of children. Almost half of the admitted children received antibiotics. Two patients died, including a toddler. Both had significant complicating factors. The demographic and clinical findings presented may be useful for health care planning and patient management in Campylobacter outbreaks both in primary health care and in hospitals.

Indexed as

Disease OutbreaksAdolescentAdultAgedAged, 80 and overCampylobacter InfectionsCampylobacter jejuniChildChild, PreschoolFemaleHumansInfantInfant, NewbornMaleMiddle AgedNorway

Identifiers

PMID33755697
PMCPMC7987138
OpenAlexW3138225294

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.